Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025

Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025

ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) ('Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today announced, in collaboration with EURETINA, the winner of the Ramin Tadayoni Award 2025.

Oculis and Euretina Announce 2025 Ramin Tadayoni Award Winner

Oculis announced the recipient of the Ramin Tadayoni Award 2025, in collaboration with Euretina. This year’s honor goes to Prithvi Ramtohul, MD, recognized for his research in retinal imaging and his work on the long-lasting plasticity of intrinsic neuronal excitability in retinal ganglion cells. The Ramin Tadayoni Award, established in 2024, commemorates the life and contributions of the late Professor Ramin Tadayoni, Oculis’ former Chief Scien…

Ramin Tadayoni Award 2025 winner announced at EURETINA Congress

Prithvi Ramtohul, MD, is a PhD candidate based in Marseille, France and previously completed a fellowship in Paris under Prof. Tadayoni.